John Spencer Emtage
20Patents
12h-index
14Co-inventors
78Inventor score
Filing activity: Mar 24, 1980 → Sep 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4816397A | Multichain polypeptides or proteins and processes for their production | Chemistry; Metallurgy | 1,069 | Expired |
| US5859205A | Humanised antibodies | Chemistry; Metallurgy | 1,044 | Expired |
| US6632927B2 | Humanized antibodies | Chemistry; Metallurgy | 507 | Expired |
| US6180377A | Humanized antibodies | Chemistry; Metallurgy | 216 | Expired |
| US5994510A | Recombinant antibodies specific for TNF.alpha. | Chemistry; Metallurgy | 137 | Expired |
| US7566771B1 | Humanised antibodies | Chemistry; Metallurgy | 49 | Expired |
| US7262050B2 | Humanised antibodies | Chemistry; Metallurgy | 36 | Expired |
| US4349629A | Plasmid vectors, production anduse thereof | Chemistry; Metallurgy | 29 | Expired |
| US7244832B2 | Humanised antibodies | Chemistry; Metallurgy | 24 | Expired |
| US7241877B2 | Humanised antibodies | Chemistry; Metallurgy | 24 | Expired |
| US7244615B2 | Humanized antibodies | Chemistry; Metallurgy | 22 | Expired |
| US5998586A | Interleukin-5 specific recombinant antibodies | Chemistry; Metallurgy | 12 | Expired |
| US4357421A | Synthetic gene coding for influenza hemagglutinin | Chemistry; Metallurgy | 11 | Expired |
| US6013642A | Use of estrone derivatives as steroid sulphatase inhibitors | Human Necessities | 9 | Expired |
| US6734286B2 | Interleukin-5 specific recombinant antibodies | Chemistry; Metallurgy | 8 | Expired |
| US6316227A | Nucleic acids encoding interleukin-5 specific recombinant antibodies | Chemistry; Metallurgy | 8 | Expired |
| USRE39548E1 | Interleukin-5 specific recombinant antibodies | General | 3 | Expired |
| USRE48787E1 | Humanised antibodies | General | 2 | Active |
| USRE50178E1 | Humanised antibodies | General | 0 | Active |
| US5747290A | Process for the production of recombinant polypeptides | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.